Cardiac Safety Services Market

Cardiac Safety Services Market Size By Type (Integrated Service and Standalone Service), By Service Type (ECG/Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies, and Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, and Others), Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13301
  • Published Date: Feb, 2023
  • Pages: 110
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global cardiac safety services market was valued at USD 0.9 billion in 2022 and is anticipated to growing at a CAGR of 11.8% from 2023 to 2032. The global cardiac safety services market is expected to reach USD 2.7 billion by 2032. Asia Pacific is expected to grow the fastest during the forecast period. 

Market Introduction:

Clinical trials, investigations, and other research required for the monitoring of heart safety are assisted by and designed by cardiac safety services. The main focus of cardiac safety services is monitoring the complete cardiac safety profile across all phases of clinical trials, from Phase I to Phase IV. While creating cardiac safety clinical trials and studies, guidelines and rules are followed by the majority of significant and reputable medical authorities of various nations and other regulating agencies. Along with the QT tests, these services include physiologic stress testing, non-invasive cardiac imaging, platelet aggregation, ambulatory blood pressure monitoring, and other things. Due to the peculiarity of standalone services, integrated services that offer cardiac safety services are typically preferred over standalone services due to the grouping of services with an emphasis on end-to-end development. Cardiovascular safety liabilities, such as pharmaceuticals with cardiovascular and non-cardiovascular effects, impact all cardiovascular system components, including the heart, blood vessels, and blood constituents. Cardiovascular side effects can occur as a result of either acute or long-term treatment and can be functional or structural (such as histopathology). In an era of increasing public scrutiny, rising company costs, and constrained regulatory agency resources, the need for efficient yet secure drug development is more critical than ever. The leading cause of death worldwide is cardiovascular disease (CVD), which accounts for 17.9 million deaths annually. The heart and blood vessel disorders known as CVDs include cerebral vascular disease, coronary heart disease, rheumatic heart disease, and other conditions.

Cardiac Safety Services Market

Get an overview of this study by requesting a free sample

Recent Development
  • In November 2021, Clario was created by the merger of ERT and Bioclinica. The purchase combines ERT's expertise in eCOA, cardiac safety, respiratory, and wearables with Bioclinica's expertise in imaging, eClinical software, and drug safety solutions.
  • In June 2021, ERT announced the addition of an at-home blood pressure monitoring solution to its clinical endpoint data collecting portfolio. This solution improves safety evaluation and patient compliance while also increasing patient compliance.
  • In February 2021, to deliver care management solutions for cardiac and other patients at hospitals and homes, Royal Phillips, a global leader in health technology, purchased BioTelemetry. BioTelemetry is a US-based provider of remote cardiac diagnostics and monitoring.

Market Dynamics:

Drivers

Increase in the number of clinical trials- The foundation of the regulatory standards necessary for a drug to be licensed is still a clinical study, a well-structured system dating back hundreds of years. Recent developments in clinical trials have boosted the number of studies and are projected to fuel the market's expansion. The regulatory framework for clinical trials has undergone several adjustments, which have increased the number of trials and improved their outcomes. According to the Medical News article, the rise in the caliber of clinical trials, including the requirement of staff training, has led to a significant increase in the number of studies.

Restraints:

Lack of skilled professionals- The pharmaceutical, biotechnology, and medical device R&D outsourcing industries constantly evolve. Highly qualified professionals must provide high-quality services, follow accepted laboratory practices, and keep up with current medical device and pharmaceutical R&D technologies and methodologies advancements. CROs face challenges in attracting and retaining highly talented workers as they compete for trained and experienced scientists in the biotechnology, pharmaceutical, and medical device industries and research and academic organizations.

Opportunities:

A rise in discoveries- The discovery and development of new medications for treating diseases rely heavily on clinical trials. It is the most effective technique for researchers to learn which therapies are effective or ineffective for people. Developing novel medications or medical devices to address diseases including cancer, endocrine, metabolic, and others is known as drug development. Therefore, clinical trials are the most efficient way to determine the therapeutic drug's safety and effectiveness before it is released onto the market and consumed by humans. This includes cardiac safety evaluation, a crucial step before any medical product is released onto the market.

Challenges:

Maintenance issues- It's crucial to evaluate and report clinical cardiac safety data Therefore, it is vital to give and carry out cardiac safety evaluation following legal procedure; otherwise, the product may not be approved on time, which is anticipated to slow the expansion of the market. Between 1957 and 2007, there were 47 instances of post-marketing drug withdrawal, of which 45% were attributed to worries about cardiovascular damage, according to the IQVIA article. Similarly, 27% of prospective novel medication compounds that failed in the preclinical phase during the past 20 years did so due to cardiovascular toxicity since they did not achieve the regulatory standards.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest global cardiac safety services market, with a 38.8% market revenue share in 2022.

North America currently dominates the cardiac safety services market. Due to the rising number of elderly patients and the high incidence of cardiovascular illnesses, North America is anticipated to account for a significant portion of the market for cardiac safety services during the forecast period. According to data from the American Heart Association released in 2020, there are roughly 605,000 new cases of heart attacks and 200,000 recurrent heart attacks reported each year in the country. People now have a higher risk of developing cardiac illnesses due to COVID-19. For instance, after a year, heart failure risk was increased by 72% for US veterans with COVID-19.

The Asia Pacific market is expected to rise during the forecast period. A wide range of economic and social factors, including the financial arrangements and organizational structure of the health system, influence the amount of money the region spends on healthcare and its growth rate over time. As the average person's disposable income rises, healthcare spending has increased in developed and developing nations.

North America Region Cardiac Safety Services Market Share in 2022 - 38.8%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Type segment analysis

The type segment is divided into integrated service and standalone service. The integrated services segment dominated the market, with a market share of around 60% in 2022. A broad variety of cardiac safety services, including imaging, TQT, and profile QT tests, are offered by these state-of-the-art core lab services. They also keep an eye on off-target cardiovascular liabilities and perform on-site multichannel telemetry under the direction of professional nurses to assist with the real-time evaluation of heart rate and rhythm.

Service Type segment analysis

The service type segment is divided into ECG/Holter measurement, blood pressure measurement, cardiovascular imaging, thorough QT studies, and others. Over the forecast period, the ECG/Holter measurement segment is expected to grow at the fastest CAGR of 12.9%. Smartwatches and other personal electronics offer electrocardiogram monitoring. A small, portable device known as a Holter monitor is employed to record heartbeats. It is used to recognize and assess the possibility of abnormal heartbeats (arrhythmias).

End-User segment analysis

The end-user segment is divided into pharmaceutical and biopharmaceutical companies, contract research organizations, and others. The contract research organizations segment dominated the market, with a market share of around 44% in 2022. Contract research organizations (CROs) conduct clinical trials for pharmaceuticals, medical devices, biotechnology industries, educational institutions, governmental organizations, and charities.

Some of the Key Market Players:
  • Koninklijke Philips N.V.
  • Laboratory Corporation of America Holdings
  • IQVIA
  • Ncardia
  • Certara
  • SGS SA
  • Banook
  • Celerion
  • Biotrial
  • NEXEL Co., Ltd
  • Richmond Pharmacology
  • PhysioStim
  • Shanghai Medicilon Inc
  • Clario

Report Description: 

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 0.9 billion
Market size value in 2032 USD 2.7 billion
CAGR (2023 to 2032) 11.8%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Regional Segments North America, Asia Pacific, Europe, Latin America, Middle East and Africa
Segments Type, Service Type, End-User

Frequesntly Asked Questions

As per The Brainy Insights, the size of the cardiac safety services market was valued at USD 0.9 billion in 2022 to USD 2.7 billion by 2032.

The global cardiac safety services market is growing at a CAGR of 11.8% during the forecast period 2023-2032.

North America emerged as the largest market for cardiac safety services.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Type
          4.3.2. Market Attractiveness Analysis By Service Type
          4.3.3. Market Attractiveness Analysis By End-User
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increase in the number of clinical trials
    5.3. Restraints
          5.3.1. Lack of skilled professionals
    5.4. Opportunities
          5.4.1. Rise in discoveries
    5.5. Challenges
          5.5.1. Maintenance issues

6. Global Cardiac Safety Services Market Analysis and Forecast, By Type
    6.1. Segment Overview
    6.2. Integrated Service
    6.3. Standalone Service

7. Global Cardiac Safety Services Market Analysis and Forecast, By Service Type
    7.1. Segment Overview
    7.2. ECG/Holter Measurement
    7.3. Blood Pressure Measurement
    7.4. Cardiovascular Imaging
    7.5. Thorough QT Studies
    7.6. Others

8. Global Cardiac Safety Services Market Analysis and Forecast, By End-User
    8.1. Segment Overview
    8.2. Pharmaceutical and Biopharmaceutical Companies
    8.3. Contract Research Organizations
    8.4. Others

9. Global Cardiac Safety Services Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Cardiac Safety Services Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in Global Cardiac Safety Services Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Koninklijke Philips N.V.
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Laboratory Corporation of America Holdings
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. IQVIA
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Ncardia
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Certara
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. SGS SA
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Banook
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Celerion
          11.8.1. Business Overview
          11.8.2. Company Snapshotx`
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Biotrial
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. NEXEL Co., Ltd
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
    11.11. Richmond Pharmacology
          11.11.1. Business Overview
          11.11.2. Company Snapshot
          11.11.3. Company Market Share Analysis
          11.11.4. Company Product Portfolio
          11.11.5. Recent Developments
          11.11.6. SWOT Analysis
    11.12. PhysioStim
          11.12.1. Business Overview
          11.12.2. Company Snapshot`
          11.12.3. Company Market Share Analysis
          11.12.4. Company Product Portfolio
          11.12.5. Recent Developments
          11.12.6. SWOT Analysis
    11.13. Shanghai Medicilon Inc
          11.13.1. Business Overview
          11.13.2. Company Snapshot
          11.13.3. Company Market Share Analysis
          11.13.4. Company Product Portfolio
          11.13.5. Recent Developments
          11.13.6. SWOT Analysis
    11.14. Clario
          11.14.1. Business Overview
          11.14.2. Company Snapshot
          11.14.3. Company Market Share Analysis
          11.14.4. Company Product Portfolio
          11.14.5. Recent Developments
          11.14.6. SWOT Analysis
 

List of Table

1. Global Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

2. Global Integrated Service, Cardiac Safety Services Market, By Region, 2019-2032 (USD Billion) 

3. Global Standalone Service, Cardiac Safety Services Market, By Region, 2019-2032 (USD Billion) 

4. Global Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

5. Global ECG/Holter Measurement, Cardiac Safety Services Market, By Region, 2019-2032 (USD Billion)

6. Global Blood Pressure Measurement, Cardiac Safety Services Market, By Region, 2019-2032 (USD Billion)

7. Global Cardiovascular Imaging, Cardiac Safety Services Market, By Region, 2019-2032 (USD Billion)

8. Global Thorough QT Studies, Cardiac Safety Services Market, By Region, 2019-2032 (USD Billion)

9. Global Others, Cardiac Safety Services Market, By Region, 2019-2032 (USD Billion)

10. Global Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

11. Global Pharmaceutical and Biopharmaceutical Companies, Cardiac Safety Services Market, By Region, 2019-2032 (USD Billion)

12. Global Contract Research Organizations, Cardiac Safety Services Market, By Region, 2019-2032 (USD Billion)

13. Global Others, Cardiac Safety Services Market, By Region, 2019-2032 (USD Billion)

14. North America Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

15. North America Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

16. North America Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

17. U.S. Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

18. U.S. Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

19. U.S. Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

20. Canada Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

21. Canada Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

22. Canada Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

23. Mexico Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

24. Mexico Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

25. Mexico Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

26. Europe Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

27. Europe Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

28. Europe Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

29. Germany Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

30. Germany Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

31. Germany Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

32. France Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

33. France Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

34. France Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

35. U.K. Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

36. U.K. Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

37. U.K. Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

38. Italy Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

39. Italy Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

40. Italy Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

41. Spain Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

42. Spain Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

43. Spain Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

44. Asia Pacific Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

45. Asia Pacific Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

46. Asia Pacific Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

47. Japan Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

48. Japan Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

49. Japan Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

50. China Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

51. China Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

52. China Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

53. India Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

54. India Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

55. India Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

56. South America Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

57. South America Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

58. South America Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

59. Brazil Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

60. Brazil Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

61. Brazil Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

62. Middle East and Africa Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

63. Middle East and Africa Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

64. Middle East and Africa Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

65. UAE Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

66. UAE Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

67. UAE Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

68. South Africa Cardiac Safety Services Market, By Type, 2019-2032 (USD Billion)

69. South Africa Cardiac Safety Services Market, By Service Type, 2019-2032 (USD Billion)

70. South Africa Cardiac Safety Services Market, By End-User, 2019-2032 (USD Billion)

List of Figures 

1. Global Cardiac Safety Services Market Segmentation

2. Global Cardiac Safety Services Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Cardiac Safety Services Market Attractiveness Analysis By Type

9. Global Cardiac Safety Services Market Attractiveness Analysis By Service Type

10. Global Cardiac Safety Services Market Attractiveness Analysis By End-User

11. Global Cardiac Safety Services Market Attractiveness Analysis By Region

12. Global Cardiac Safety Services Market: Dynamics

13. Global Cardiac Safety Services Market Share By Type (2023 & 2032)

14. Global Cardiac Safety Services Market Share By Service Type (2023 & 2032)

15. Global Cardiac Safety Services Market Share By End-User (2023 & 2032)

16. Global Cardiac Safety Services Market Share By Regions (2023 & 2032)

17. Global Cardiac Safety Services Market Share By Company (2022)

This study forecasts global, regional, and country revenue from 2019 to 2032. Brainy Insights has segmented the global cardiac safety services market based on the below-mentioned segments:

Global Cardiac Safety Services Market by Type:

  • Integrated Service
  • Standalone Service

Global Cardiac Safety Services Market by Service Type:

  • ECG/Holter Measurement
  • Blood Pressure Measurement
  • Cardiovascular Imaging
  • Thorough QT Studies
  • Others

Global Cardiac Safety Services Market by End-User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research Organizations
  • Others

Global Cardiac Safety Services Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date